Chemoinformaics analysis of 5,7-DIHYDROXY-3-(4-HYDROXY-3-METHOXYPHENYL)CHROMEN-4-ONE
| Molecular Weight | 300.266 | nRot | 2 |
| Heavy Atom Molecular Weight | 288.17 | nRig | 18 |
| Exact Molecular Weight | 300.063 | nRing | 3 |
| Solubility: LogS | -3.574 | nHRing | 1 |
| Solubility: LogP | 2.425 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 39.5335 |
| nHD | 3 | BPOL | 16.3785 |
| QED | 0.672 |
| Synth | 2.373 |
| Natural Product Likeliness | 1.394 |
| NR-PPAR-gamma | 0.935 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.953 |
| HIA | 0.01 |
| CACO-2 | -4.841 |
| MDCK | 0.0000083 |
| BBB | 0.014 |
| PPB | 0.965795 |
| VDSS | 0.557 |
| FU | 0.0449522 |
| CYP1A2-inh | 0.97 |
| CYP1A2-sub | 0.807 |
| CYP2c19-inh | 0.429 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.703 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.813 |
| CYP2d6-sub | 0.841 |
| CYP3a4-inh | 0.667 |
| CYP3a4-sub | 0.114 |
| CL | 7.709 |
| T12 | 0.892 |
| hERG | 0.039 |
| Ames | 0.171 |
| ROA | 0.234 |
| SkinSen | 0.917 |
| Carcinogencity | 0.162 |
| EI | 0.943 |
| Respiratory | 0.151 |
| NR-Aromatase | 0.761 |
| Antiviral | Yes |
| Prediction | 0.781209 |